a
Biogenetech

Related Posts

    Sorry, no posts matched your criteria.

Bharat Biotech Announces Phase 3 Results of COVAXIN India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%

Bharat Biotech Announces Phase 3 Results of COVAXIN India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%

Home   /   News   /   Bharat Biotech Announces Phase 3 Results of COVAXIN India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%